Delivery Order SPE2DB22D3501-SPE2DB25FVJ26

Award Date 4/21/25
Potential Completion Date 4/22/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,218.78 firm fixed-price delivery order is for the supply of 100 units of the medication Meloxicam 15 mg Tablet. The contract has a completion date of May 21, 2025 and is not set aside for any particular business classification. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,555,991 units of Meloxicam 15 mg tablets. The contract is a Firm Fixed Price Delivery Order valued at $1,637.96 with a completion date of November 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a...
This federal contract award, identified as SPE2DX15D3005|SPE2DX25F3MQX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The contract, valued at $17,697.34, is for the delivery of 4,566,307,554 units of Meloxicam 15 mg tablets. It is a firm fixed-price delivery order contract with a period of performance through November 4, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $43,151.10 fixed-price contract is for the supply of 4,565,927 units of the pharmaceutical drug Meloxicam 15 mg tablet. The delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,269.10, is for the delivery of 180 tablets of the medication Meloxicam 15 mg. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of June 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award, valued at $44,430.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,566,211,113 tablets of the medication Meloxicam 15 mg, with a firm fixed price and an ultimate completion date of October 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,853.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Meloxicam 7.5 mg tablets in 90-count packages. This appears to be a firm-fixed-price delivery order contract, with an ultimate completion date of April 3, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of 4,566,281,392 units of 15 mg Meloxicam tablets over a period ending on October 31, 2024. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $39,305.93. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a $1,223.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Meloxicam 15 mg tablet units, a medication commonly used to treat pain and inflammation. The contract has a period of performance through June 4, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, with an ID of SPE2DB22D3004|SPE2DB24FPJ88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 180 tablets of the medication Meloxicam 15 mg, with a ceiling value of $4,978.00 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract, which is a delivery order under a larger...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVJ26
    Delivery Order

This federal contract award, with ID SPE2DB22D3501|SPE2DB25FVJ26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,415.00 firm fixed-price delivery order is for 4,567,983,177 units of the medication Meloxicam 15 mg Tablet. The contract has an ultimate completion date of April 22, 2025 and does not have a set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX. This IDC, which runs through December 2026, allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/21/25, 7:46 PM